Article
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Molecular cancer research : MCR - 1 Feb 2016
Edwards Lauren, Gupta Rohit, Filipp Fabian Volker
Abstract excerpt
UNLABELLED: New strategies are needed to diagnose and target human melanoma. To this end, genomic analyses was performed to assess somatic mutations and gene expression signatures using a large cohort of human skin cutaneous melanoma (SKCM) patients from The Cancer Genome Atlas (TCGA) project to identify critical differences between primary and metastatic tumors. Interestingly, pyrimidine metabolism is one of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
